Giovanni Antonini

机构：Saint Camillus International University of Health and Medical Sciences, Azienda Ospedaliera Sant'Andrea, Sapienza University of Rome · ORCID：0000-0002-7519-7739

发表论文 329 篇 · 总被引 11310 次 · h-index 54

代表论文

• Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study (2023 · The Lancet Neurology · 被引 289)
• An International Perspective on Preceding Infections in Guillain-Barré Syndrome (2022 · Neurology · 被引 90)
• CSF Findings in Relation to Clinical Characteristics, Subtype, and Disease Course in Patients With Guillain-Barré Syndrome (2023 · Neurology · 被引 61)
• Serum neurofilament light chain: a promising early diagnostic biomarker for hereditary transthyretin amyloidosis? (2023 · European Journal of Neurology · 被引 32)
• Real world study on prevalence, treatment and economic burden of myasthenia gravis in Italy (2023 · Heliyon · 被引 29)
• Muscle MRI in immune-mediated necrotizing myopathy (IMNM): implications for clinical management and treatment strategies (2022 · Journal of Neurology · 被引 28)